D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.2B |
| 2 |
Boston Scientific
BSX
|
+$1.05B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$934M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$924M |
| 5 |
JPMorgan Chase
JPM
|
+$922M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.2B |
| 2 |
NVIDIA
NVDA
|
+$1.58B |
| 3 |
Palantir
PLTR
|
+$901M |
| 4 |
Netflix
NFLX
|
+$883M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$805M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.42% |
| 2 | Technology | 18.55% |
| 3 | Consumer Discretionary | 8.97% |
| 4 | Financials | 8.5% |
| 5 | Healthcare | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3951
CALL
Xerox
XRX
$355M
| $323K | ﹤0.01% |
+250,000
| New | +$494K |
2026 Q1
0 quarters
|
|
3952
Vicor
VICR
$11.3B
| $322K | ﹤0.01% |
+2,000
| New | +$331K |
2026 Q1
0 quarters
|
|
3953
PUT
Acadia Healthcare
ACHC
$2.95B
| $320K | ﹤0.01% |
13,700
-14,800
| -52% | -$268K |
2025 Q3
2 quarters
|
|
3954
PUT
Global Ship Lease
GSL
$1.55B
| $316K | ﹤0.01% |
8,500
-600
| -7% | -$22.6K |
2025 Q4
1 quarter
|
|
3955
PUT
Progress Software
PRGS
$1.58B
| $315K | ﹤0.01% |
12,300
-26,100
| -68% | -$998K |
2025 Q3
2 quarters
|
|
3956
Blaize Holdings Warrants
BZAIW
$741K
| $315K | ﹤0.01% |
900,000
| – | – |
2025 Q1
4 quarters
|
|
3957
MillerKnoll
MLKN
$1.45B
| $313K | ﹤0.01% |
21,680
-141,412
| -87% | -$2.78M |
2025 Q3
2 quarters
|
|
3958
Ryanair
RYAAY
$26.6B
| $312K | ﹤0.01% |
+5,400
| New | +$356K |
2026 Q1
0 quarters
|
|
3959
First Trust Consumer Discretionary AlphaDEX Fund
FXD
$247M
| $311K | ﹤0.01% |
4,864
| – | – |
2024 Q2
7 quarters
|
|
|
WSR
3960
DELISTED
Whitestone REIT
WSR
| $310K | ﹤0.01% |
+19,220
| New | +$289K |
2026 Q1
0 quarters
|
|
3961
1-800-Flowers.com
FLWS
$177M
| $310K | ﹤0.01% |
101,934
-64,319
| -39% | -$241K |
2021 Q4
17 quarters
|
|
3962
CALL
Aurora
AUR
$10.1B
| $309K | ﹤0.01% |
+75,000
| New | +$332K |
2026 Q1
0 quarters
|
|
3963
CALL
Exelon
EXC
$43.9B
| $309K | ﹤0.01% |
6,300
-15,600
| -71% | -$726K |
2025 Q3
2 quarters
|
|
3964
Aktis Oncology
AKTS
$917M
| $305K | ﹤0.01% |
+17,062
| New | +$331K |
2026 Q1
0 quarters
|
|
3965
CALL
Kinross Gold
KGC
$26.4B
| $305K | ﹤0.01% |
+10,000
| New | +$328K |
2026 Q1
0 quarters
|
|
3966
BillionToOne Inc
BLLN
$4.62B
| $305K | ﹤0.01% |
+3,862
| New | +$316K |
2026 Q1
0 quarters
|
|
3967
Stride
LRN
$3.43B
| $305K | ﹤0.01% |
3,454
-31,495
| -90% | -$2.55M |
2022 Q4
13 quarters
|
|
3968
1RT Acquisition Corp
ONCH
$223M
| $304K | ﹤0.01% |
29,947
+19,947
| +199% | +$203K |
2025 Q3
2 quarters
|
|
3969
PUT
Verisk Analytics
VRSK
$23.5B
| $304K | ﹤0.01% |
1,600
| – | – |
2025 Q4
1 quarter
|
|
3970
CALL
Eagle Materials
EXP
$5.01B
| $303K | ﹤0.01% |
+1,600
| New | +$340K |
2026 Q1
0 quarters
|
|
3971
CALL
Incyte
INCY
$22.6B
| $301K | ﹤0.01% |
3,200
| – | – |
2025 Q4
1 quarter
|
|
3972
Ollie's Bargain Outlet
OLLI
$5.53B
| $300K | ﹤0.01% |
3,262
-18,080
| -85% | -$1.95M |
2021 Q4
17 quarters
|
|
3973
Columbia Research Enhanced Core ETF
RECS
$6.16B
| $300K | ﹤0.01% |
+7,702
| New | +$312K |
2026 Q1
0 quarters
|
|
3974
Hafnia
HAFN
$5.7B
| $299K | ﹤0.01% |
39,327
-71,588
| -65% | -$475K |
2025 Q3
2 quarters
|
|
3975
ACNB Corp
ACNB
$636M
| $298K | ﹤0.01% |
6,233
+1,056
| +20% | +$52.1K |
2025 Q1
4 quarters
|
|
Similar funds
D.E. Shaw & Co's Q1 2026 Portfolio in Review
As of Q1 2026, D.E. Shaw & Co held 5,226 positions worth $166B, down 8.8% from $182B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co withdrew a net $5.92B in Q1 2026, closing 756 positions and reducing 1,922 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $805M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, down from 36% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, D.E. Shaw & Co opened a new position in Venture Global Inc worth $211M.
- D.E. Shaw & Co's largest Q1 2026 buy was Venture Global Inc: 13,410,074 shares worth $211M.
- D.E. Shaw & Co added most to Broadcom in Q1 2026, an estimated $1.2B increase.
- D.E. Shaw & Co's biggest Q1 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.2B.
- D.E. Shaw & Co fully exited iShares Core S&P 500 ETF in Q1 2026, selling an estimated $805M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $166B portfolio in Q1 2026.
- D.E. Shaw & Co opened 685 new positions and closed 756 in Q1 2026.
- D.E. Shaw & Co's portfolio value fell 8.8% quarter-over-quarter to $166B.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.